✦ LIBER ✦

A phase l study of three different dosing schedules of the oral aurora kinase inhibitor MSC1992371A in patients with solid tumors

✍ Scribed by M. Mita, M. Gordon, N. Rejeb, A. Gianella-Borradori, V. Jego, A. Mita…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I schedule dependency study of t

✍ Raymond, E.; Alexandre, J.; Faivre, S.; Goldwasser, F.; Besse-Hammer, T.; Gianel 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 270 KB

A phase I dose-escalation study of MSC19

✍ Graux, Carlos; Sonet, Anne; Maertens, Johan; Duyster, Justus; Greiner, Jochen; C 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 526 KB

Phase I dose escalation study of MK-0457

✍ Anne M. Traynor; Maureen Hewitt; Glenn Liu; Keith T. Flaherty; Jason Clark; Stev 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 252 KB

Phase 1 study of MLN8054, a selective in

✍ E. Claire Dees; Jeffrey R. Infante; Roger B. Cohen; Bert H. O’Neil; Suzanne Jone 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 328 KB

Phase I study of barasertib (AZD1152), a

✍ Gary K. Schwartz,Richard D. Carvajal,Rachel Midgley… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 389 KB

418 Phase I, clinical, pharmacokinetic a

✍ E. Raymond; J. Alexandre; T. Besse-Hammer; S. Faivre; B. Longerey; N. Rejeb; A. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB